Study of Oxidized Albumin in Liver Transplant Patients
Launched by REGION STOCKHOLM · Jan 8, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the changes in a protein called albumin in patients who are undergoing a liver transplant. Albumin plays an important role in the body, and the trial aims to understand how its condition changes before, during, and after the transplant. Researchers will collect samples from 10 patients to look at various related factors, such as how well the body is handling stress and inflammation during the transplant process.
To be eligible for this study, patients must be on the waiting list for a liver transplant and be between the ages of 65 and 74. There are no specific exclusions based on health conditions for this trial. Participants can expect to provide samples at several key points: before the transplant, during the surgery, and on the first few days after the operation. This study is important because it could help doctors learn more about how to improve care for liver transplant patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients on waiting list for liver transplantation
- Exclusion Criteria:
- • none
About Region Stockholm
Region Stockholm is a leading healthcare authority committed to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, Region Stockholm collaborates with hospitals, research institutions, and industry partners to facilitate the development of new therapies and treatment protocols. With a focus on quality, safety, and ethical standards, the organization aims to enhance health outcomes for the diverse population of Stockholm and beyond, leveraging cutting-edge research to translate scientific discoveries into effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported